These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 6164019
1. [The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey]. Molinatti GM, Limone P. Minerva Med; 1981 Mar 31; 72(12):715-32. PubMed ID: 6164019 [Abstract] [Full Text] [Related]
2. Clinical implications of renin in the hypertensive patient. Brunner HR, Gavras H. JAMA; 1975 Sep 08; 233(10):1091-3. PubMed ID: 1174160 [No Abstract] [Full Text] [Related]
3. Control of aldosterone secretion by the renin-angiotensin system and by corticotropin. Gross F. Adv Intern Med; 1968 Sep 08; 14():281-339. PubMed ID: 4303034 [No Abstract] [Full Text] [Related]
4. The renin-angiotensin system and aldosterone in hypertension: a brief review of some aspects. Fraser R, Brown JJ, Lever AF, Morton JJ, Robertson JI. Int J Obes; 1981 Sep 08; 5 suppl 1():115-23. PubMed ID: 7016779 [Abstract] [Full Text] [Related]
8. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function. Atlas SA, Niarchos AP, Case DB. Am J Nephrol; 1983 Sep 08; 3(2-3):118-27. PubMed ID: 6191567 [No Abstract] [Full Text] [Related]
9. The renin-angiotensin system (first of two parts). Oparil S, Haber E. N Engl J Med; 1974 Aug 22; 291(8):389-401. PubMed ID: 4367917 [No Abstract] [Full Text] [Related]
20. Studies on the renin-angiotensin-aldosterone system in elderly hypertensive patients with an angiotensin II antagonist. Ogihara T, Hata T, Maruyama A, Mikami H, Nakamaru M, Mandai T, Kumahara Y. Clin Sci (Lond); 1979 Nov 22; 57(5):461-3. PubMed ID: 519955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]